- Home
- HURN vs BEAM Comparison
HURN vs BEAM Comparison
Compare HURN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURN
- BEAM
- Stock Information
- Founded
- HURN 2002
- BEAM 2017
- Country
- HURN United States
- BEAM United States
- Employees
- HURN N/A
- BEAM N/A
- Industry
- HURN Professional Services
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HURN Consumer Discretionary
- BEAM Health Care
- Exchange
- HURN Nasdaq
- BEAM Nasdaq
- Market Cap
- HURN 2.2B
- BEAM 1.9B
- IPO Year
- HURN 2004
- BEAM 2020
- Fundamental
- Price
- HURN $128.75
- BEAM $24.41
- Analyst Decision
- HURN Strong Buy
- BEAM Buy
- Analyst Count
- HURN 4
- BEAM 10
- Target Price
- HURN $133.00
- BEAM $47.67
- AVG Volume (30 Days)
- HURN 86.0K
- BEAM 1.2M
- Earning Date
- HURN 02-25-2025
- BEAM 02-25-2025
- Dividend Yield
- HURN N/A
- BEAM N/A
- EPS Growth
- HURN 16.41
- BEAM N/A
- EPS
- HURN 4.52
- BEAM N/A
- Revenue
- HURN $1,436,892,000.00
- BEAM $349,643,000.00
- Revenue This Year
- HURN $11.38
- BEAM N/A
- Revenue Next Year
- HURN $8.50
- BEAM $14.08
- P/E Ratio
- HURN $28.60
- BEAM N/A
- Revenue Growth
- HURN 7.51
- BEAM 328.73
- 52 Week Low
- HURN $84.26
- BEAM $20.84
- 52 Week High
- HURN $131.06
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- HURN 63.56
- BEAM 42.12
- Support Level
- HURN $126.73
- BEAM $22.50
- Resistance Level
- HURN $128.83
- BEAM $28.39
- Average True Range (ATR)
- HURN 2.73
- BEAM 1.56
- MACD
- HURN 0.43
- BEAM -0.33
- Stochastic Oscillator
- HURN 91.19
- BEAM 27.67
About HURN Huron Consulting Group Inc.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in strategy, technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Business Advisory. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Business Advisory segment provides services to large and middle-market organizations, not-for-profit organizations, and private equity firms. It generates a majority of its revenue from the Healthcare Segment.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.